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To understand development we need to understand how transcriptional regulatory mechanisms are
employed to confer different cell types with their unique properties. Nonetheless it is also critical to
understand how such mechanisms are used to confer different cell types with common cellular prop-
erties, such as the ability to adhere to the extracellular matrix. To decode how adhesion is regulated in
cells stemming from different pedigrees we analyzed the regulatory region that drives the expression of
Dei, which is a transcription factor that serves as a central determinant of cell adhesion, particularly by
inducing expression of βPS-integrin. We show that activation of dei transcription is mediated through
multiple cis regulatory modules, each driving transcription in a spatially and temporally restricted
fashion. Thus the dei gene provides a molecular platform through which cell adhesion can be regulated at
the transcriptional level in different cellular milieus. Moreover, we show that these regulatory modules
respond, often directly, to central regulators of cell identity in each of the dei-expressing cell types, such
as D-Mef2 in muscle cells, Stripe in tendon cells and Blistered in wing intervein cells. These ﬁndings
suggest that the acquirement of common cellular properties shared by different cell types is embedded
within the unique differentiation program dictated to each of these cells by the major determinants of its
identity.
& 2015 Elsevier Inc. All rights reserved.Introduction
During the process of differentiation each cell-type produces a
distinct set of proteins that are required for establishing its unique
structural and functional properties. Cells that share functional
properties need to express similar sets of proteins that endow
them with these speciﬁc features, even if they originate in differ-
ent tissues and their fates are determined by different tissue-
speciﬁc selector genes. For example, various types of ‘sticky’ cells
that adhere strongly to the extracellular matrix need to express
alpha and beta integrin chains to be able to adhere properly. If
such cells fail to express the right levels of integrins cell adhesion
is impaired leading to defects in cell function and tissue integrity
(e.g. Zusman et al., 1990; Brown, 1994; Brabant et al., 1996). We
have recently shown that the bHLH transcription factor Taxi
wings/Delilah (Dei) is a potent activator of βPS integrin expression
in various cell types in Drosophila (Egoz-Matia et al., 2011). Thus,
Dei may act as a molecular switch that promotes the differentia-
tion program of adhesive cell types by regulating the expression of
βPS integrin and perhaps additional cell adhesion molecules.).Given its pivotal role as a mediator between signaling pathways
that specify sticky cell fates and βPS integrin, it is not surprising
that Dei is expressed in a large repertoire of cell types in a spatially
and temporally dynamic fashion. In the embryo dei is expressed
mainly in the contractile and proprioceptive systems. dei is tran-
scribed in the visceral and somatic mesoderm starting at em-
bryonic stage 12 (Armand et al., 1994; Artero et al., 2003). Its
mesodermal expression is conﬁned to fusion competent myoblasts
(FCM) and it declines during stage 14, concomitantly with the
fusion of FCM with founder cells and the increasing expression of
dei in muscle attachment cells (Armand et al., 1994; Artero et al.,
2003). The expression of dei in muscle attachment cells starts at
late stage 13 and it continues till the end of embryogenesis (Ar-
mand et al., 1994; Yarnitzky et al., 1997). In the chordotonal organs
(ChOs) the dei gene is expressed in the support cells (cap and li-
gament) and attachment cells (cap-attachment [CA] and ligament-
attachment [LA] cells) and is excluded from the adjacent neuron
and scolopale cells (Inbal et al., 2004). During pupal stages, Dei is
expressed in intervein regions of the wing and in cone cells in the
eye. Changes in the level of Dei expression in these cells lead to
concomitant alteration in βPS Integrin expression (Egoz-Matia
et al., 2011).
Each of the above-mentioned cell types constitutes a uni
que genetic milieu. They express different combinations of
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pathways, and are exposed to different signals from their
neighbors. Despite these differences, they all must activate the
expression of dei as part of their differentiation program. As a
ﬁrst step towards understanding how the dei gene responds to
different signaling pathways and transcription factors in various
developmental contexts, we have analyzed the regulatory region
of the dei gene. Here we show that the dei locus harbors multiple
discrete cis regulatory modules (CRM) that respond to different
transcription factors at speciﬁc time points and drive dei's ex-
pression in different subsets of the dei-expressing cells. These
regulatory elements are located upstream to the transcription
start site and within the single intron of the gene. Analyses of the
expression patterns driven by these regulatory elements allowed
the identiﬁcation of upstream regulators of dei expression and
revealed a bi-phasic pattern of expression in muscles and ChOs.
Further analysis of an attachment cell-speciﬁc regulatory module
identiﬁed the EGR protein Stripe as a direct regulator of dei in
these cells. The modularity of the CRMs in the dei locus, high-
lighted in this work, probably accounts for the dynamic devel-
opmental expression pattern of the dei gene and can mediate the
dynamic need for adhesive properties in changing genetic
environment.Materials and methods
Fly strains
deie01478, en-Gal4 (FlyBase; St Pierre et al., 2014), bs14 (Fristrom
et al., 1994), sr155 (Usui et al., 2004), mef22.21 (Bour et al., 1995),
UAS-srA (Volohonsky et al., 2007), UAS-srB (Becker et al., 1997). To
generate bs14 homozygous clones we recombined the bs14 allele
onto a FRT42D chromosome, crossed this recombinant to yw,
hsFLP; FRT42D, Ubi-GFP and heat-shocked 2nd instar larvae for 1 h
at 37 °C. Homozygous mutant clones were identiﬁed based on the
concomitant loss of GFP and Bs expression. For the rescue ex-
periment we have recombined the following Gal4 drivers from the
Janelia collection (Pfeiffer et al., 2008) to dei33-2 (Egoz-Matia et al.,
2011): P{GMR12D06-GAL4}attP2 (#46136), P{GMR12H09-GAL4}
attP2 (#47458), P{GMR13A10-GAL4}attP2 (#48540) and crossed
them to UAS-dei; dei33-2/TM6B, abdA-lacZ.
Generation of DNA constructs and transgenic ﬂies
The deiintron and deiupstream fragments were ampliﬁed from
genomic DNA by PCR, using the Expand Long Template PCR Sys-
tem (Roche) and cloned into the pGEM-T-easy vector (Promega).
These constructs were used as templates for amplifying the
shorter regulatory fragments (the PCR primers are listed in Table
S1). Next, the different fragments were subcloned, using NotI, into
the pH-Pelican vector (Barolo et al., 2000) upstream to the lacZ
reporter gene. The reporter constructs were introduced into white
ﬂies using P-element mediated germline transformation (either in
house, or by Genetic Services Inc., Cambridge, Massachusetts,
USA). At least two different transgenic ﬂies for each construct were
tested.
Point mutations were introduced into the deiattachment module,
based on previously described mutagenesis of the core sites of
EGR1 (Dey et al., 1994; Ebert et al., 1994), using the QuikChange II
XL site directed mutagenesis kit (Stratagene) using the appropriate
primers (Table S2). The deiattachment-m1þ2þ3þ4 construct was gen-
erated sequentially by starting from the deiattachment-m3þ4 construct
and mutating the additional potential Sr binding sites one at a
time. Each of the four mutant variants and the original deiattachment
fragment were subcloned into the NotI site of the placZ-attB vector(Bischof et al., 2007). Transgenic strains were generated using the
PhiC31 mediated site-speciﬁc integration system. All constructs
were injected into the same docking site at location 22A on
chromosome 2L, using y1 M{vas-int.Dm}ZH-2Aw*; M{3xP3-RFP.
attP'}ZH-22A ﬂies (Bischof et al., 2007). Embryo injections were
performed by the transformation services of "CBM – Severo
Ochoa" (Madrid, Spain).
Immunohistochemistry and in situ hybridization
To generate a lacZ-speciﬁc probe, an 800 bp fragment was
ampliﬁed from the coding sequence of the gene using the fol-
lowing primers: GACGTCTCGTTGCTGCATAA and CGGGAAGGATC-
GACAGATT. This fragment was used as a template for synthesizing
sense and anti-sense digoxigenin-labeled riboprobes. Whole-
mount in-situ hybridization was carried out as described in Klein
et al. (2010). Immuno-staining of whole-mount embryos was
performed using standard techniques. Immuno-staining of pupal
tissues was carried out as described in Halachmi et al. (2012).
Stained embryos and pupal tissues were viewed using bright ﬁeld
and confocal microscopy (Axioskop and LSM 510, Zeiss).
Primary antibodies used in this study: Mouse anti-Cut and
Mouse anti-Lozenge (1:10 and 1:5, respectively, Developmental
Studies Hybridoma Bank at the University of Iowa), rabbit anti-Dei
(1:50; Egoz-Matia et al., 2011), guinea pig anti SrA/B (1:300;
Becker et al., 1997), mouse anti-DSRF (1:100, Active Motif, Carlsbad
CA, USA), mouse and rabbit anti-β-galactosidase (1:1000, Promega
and Cappel, respectively), rabbit anti-β3-Tub (1:2000; Leiss et al.,
1988), rabbit anti-αTub-85E (Klein et al., 2010). A new monoclonal
antibody, mouse anti-αTub-85E, was raised against amino acids
438–449 (DSTTELGEDEEY) of αTub-85E (Abmart, Shanghai, Chi-
na). Secondary antibodies for ﬂuorescent staining were Cy3, Cy2 or
Cy5-conjugated anti mouse/rabbit/rat/guinea pig (Jackson La-
boratories, Bar-Harbor, Maine, USA). Secondary antibodies for non-
ﬂuorescent staining were biotinylated anti-mouse/rabbit detected
with Vecta-Stain Elite ABC-HRP kit (Vector Laboratories, Burlin-
game, CA, USA).
Statistical analyses
The comparison of continuous data was done using General
Linear Model (Univariate; Dunnett, Duncan tests), discrete data –
by Pearson chi-square test (or Fisher exact test) and homogeneity
of Odd Ratio was examined by Breslow-Day, Tarone's statistics. The
statistical signiﬁcance was deﬁned at less than 0.05 for all tests.
Statistical analysis was executed using SPSS software package
(Release 17.0.2, SPSS Inc., 2009).Results
Two regulatory regions together reproduce the full expression pattern
of dei
The dei locus contains one non-coding exon and one coding
exon separated by a 5.8 kb intron (FlyBase; St Pierre et al., 2014)
(Fig. 1A). To identify the CRMs of the gene we used an in vivo re-
porter assay to search for tissue-speciﬁc enhancers where en-
hancer elements are often found: upstream to the transcription
start site and within the gene's single intron (Haeussler et al.,
2010; Kvon et al., 2014). The region downstream to the dei tran-
scription unit was not tested, because this region is very gene-rich
and only 85 bps separate between dei and the neighboring
downstream gene hex-t1.
To test if the upstream and intronic regions contain functional
tissue-speciﬁc regulatory elements we ﬁrst generated two large
Fig. 1. Two regulatory regions of dei together reproduce its full expression pattern. (A) Schematic representation of the dei locus and the two regulatory regions that were
studied. The 5012 bp upstream fragment is depicted as a green arrow; the 6213 bp intronic fragment is depicted as a red arrow. The two exons of the gene are depicted as
black boxes labeled 1 and 2. (B–C) Lateral view of stage 12 (B) and stage 17 (C) CS embryos stained with anti-Dei antibodies. The arrow in B points to stained haemocytes.
(D) Higher magniﬁcation of anti-Dei stained stage 17 embryo. The tendons, cap-attachment (CA), cap, ligament (Lig) and ligament-attachment (LA) cells are indicated.
(E) Dorsal view of a stage 17 embryo stained with anti-Dei antibodies. Dei-positive heart cells are indicated by an arrow. (F–G) Lateral view of stage 12 (F) and stage 17 (G)
deiintron-lacZ embryos stained with anti-βGal antibodies. The arrow in F marks the lacZ-expressing haemocytes. A close-up view of these haemocytes, doubly stained with
anti-βGal (blue) and anti-Lozenge (red) is shown in the inset in F. (H) In situ hybridization with a lacZ-speciﬁc probe to a stage 17 deiintron-lacZ embryo. Note the expression in
muscle cells and ChO cap and ligament cells. (I) Dorsal view of a stage 17 deiintron-lacZ embryo stained with anti-βGal antibodies. βGal expression in heart cells is indicated by
an arrow. (J) A deiintron-lacZ pupal wing (30–35 h after pupation) stained with anti-βGal. (K) A deiintron-lacZ pupal eye disk doubly stained with anti-βGal (blue, also shown
separately in the lower panel) and anti-Cut, which labels cone cells (red, also shown separately in the middle panel). (L–N) Lateral view of stage 12 (L) and stage 17 (M)
deiupstreamn-lacZ embryos stained with anti-βGal antibodies. The arrow in L marks the anterior group of haemocytes. (N) In situ hybridization with a lacZ-speciﬁc probe to a
stage 17 deiupstreamn-lacZ embryo. No lacZ expression is evident in muscle cells, whereas expression in tendon cells and the ChO attachment cells (CA and LA) is clearly
evident.
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non-coding exon together with the full-length intronic region of
dei, cloned upstream to lacZ in the pH-Pelican vector (Barolo et al.,
2000). The deiupstream-lacZ construct contained the ﬁrst non-coding
exon of dei along with 5.0 kb of upstream sequence, cloned
upstream to lacZ (Fig. 1A). Transgenic ﬂies harboring these con-
structs were generated and the resulting pattern of β-Gal ex-
pression was examined in embryos and pupae. This analysis
revealed that both genomic regions contain tissue-speciﬁc
enhancers that together recapitulate the full known pattern of dei
expression during embryonic and pupal stages (Table S3 and
Fig. 1B–N).
Speciﬁcally, the deiintron reporter was expressed in the cap, li-
gament and cap-attachment (CA) cells of ChOs (Fig. 1F–H) in a
manner resembling the pattern of the endogenous Dei expression:
it began at stage 12 and continued throughout embryogenesis,
with the strongest expression induced in the cap cells (Fig. 1,
compare C–D to G–H). The deiintron reporter was not expressed in
the ligament-attachment (LA) cell, the single cell within the ChO
not derived from the ChO lineage (Inbal et al., 2004). Later, during
pupal development the deiintron reporter was expressed in wing
intervein cells and in cone cells of the eye (Fig. 1J and K).
In addition to the above-mentioned cell types, the deiintron
fragment drove lacZ expression in several cell types that had not
been described before as expressing the dei gene. In particular, at
late embryonic stages deiintron reporter expression was observed in
a posterior region of the dorsal vessel (the Drosophila heart region;
Fig. 1I). Indeed, upon closer inspection we detected a low level ofendogenous Dei expression in the same region (Fig. 1E). In the
anterior region of the embryo, a high level of lacZ expression was
consistently evident in a group of Lozenge-expressing haemocytes
(Fig. 1F). Although dei expression was not documented previously
in embryonic blood cells, dei mRNA was enriched in larval blood-
cell collections containing plasmatocytes and increased lamello-
cytes population, or when subjecting larvae to bacterial challenge
(Irving et al., 2005; Kwon et al., 2008). Interestingly, the deiupstream
reporter also exhibited low levels of lacZ expression in these
haemocytes (Fig. 1L). Consistent with these ﬁndings, anti-Dei
staining revealed low levels of the Dei protein in these cells
(Fig. 1B and data not shown). The deiintron reporter was also ex-
pressed in the somatic musculature from stage 14 to 17 of em-
bryonic development (Fig. 1G–H). This late expression deviated
from the documented pattern of dei expression. However, careful
examination with anti-Dei antibodies revealed previously un-
noticed low levels of the Dei protein in muscles of late embryos
(data not shown). Thus, the high sensitivity of the reporter helped
uncover hitherto unrecognized dei expression domains.
Embryos carrying the deiupstream-lacZ transgene exhibited a
complementary expression pattern to that of deiintron-lacZ. β-Gal
expression was seen in the CA and ligament-attachment (LA) cells
of the ChOs (Fig. 1N). Expression was also observed in muscle at-
tachment cells (tendon cells) from late stage 13 till the end of
embryogenesis, similarly to the expression of the endogenous dei
gene (Fig. 1 compare C and D to M and N). In addition, β-Gal ex-
pression was observed from early stage 12 in a pattern that mimics
the endogenous dei gene in the visceral and somatic mesoderm
Fig. 2. Multiple discrete regulatory modules in the dei locus. The dei locus is represented schematically with a black line and two black boxes (exon 1 and 2). The extent of
evolutionary conservation is depicted below as a UCSC Genome Browser diagram comparing the sequence of the locus in 12 genomes. The genomic fragments tested in this
study are each represented by a bidirectional arrow. The larger deiupstreamn and deiintron fragments are depicted in green and red, respectively; the shorter fragments are
depicted in black and their names and corresponding expression patterns are shown above; n/e, not expressed. The blue arrows represent genomic fragments used to
construct the corresponding Janelia gal4 drivers.
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dei gene, which declines at stage 14, expression of the deiupstream
reporter was retained in embryonic muscles throughout embry-
ogenesis due to stability of the β-gal protein (Fig. 1M and N). Be-
low we further discuss Dei expression in the embryonic
musculature.
The two regulatory regions contain smaller discrete regulatory
modules
To elucidate the modular regulation of dei's transcription, we
further dissected the two large regulatory regions. We used the
UCSC Genome Browser (http://www.genome.ucsc.edu) to delineate
evolutionarily conserved regions within the two large fragments
that could potentially serve as CRMs. This analysis identiﬁed seven
conserved regions (Fig. 2), which were then ampliﬁed, cloned into
the pH-Pelican vector and introduced into ﬂies by germline
transformation. Anti-β-Gal staining of embryos and pupae of the
transgenic strains showed that six of the tested fragments con-
tained functional CRMs (Fig. 2). We named these shorter frag-
ments based on the 1–2 main cell types in which they induced
expression (Table S3 and Fig. 2) as described next. For the sake of
simplicity, we relate to these fragments as those that drive ex-
pression (1) mainly in pupal wing and eye tissues, (2) mainly in
embryonic muscles or (3) in tendon cells and/or ChOs.
Drosophila Serum Response Factor regulates dei wing expression via a
pupal CRM
Two regulatory fragments drove expression in pupal tissues: the
1282 bp deiwingþeye fragment induced expression in intervein regions
of the wing as well as in cone cells of the eye in a pattern similar to
that of the endogenous dei gene (Fig. 3A and B). This fragment also
induced expression in external sensory organs of the pupa including
those on the wing margin, head, notum and appendages, whereexpression of the endogenous gene has not been documented before
(Fig. 3A, C and D). The 1111 bp deiwing-margin reporter induced ex-
pression mainly in external sensory cells of the wing margin and
some external sensory organs in other appendages (Fig. 3E and F). In
previous work we identiﬁed the Drosophila Serum Response Factor
(SRF) homolog, Blistered (Bs), as a potential positive regulator of dei's
expression in intervein cells (Egoz-Matia et al., 2011). Using the
Genomatix program (http://www.genomatix.de) we discerned two
putative overlapping SRF-binding sites within the deiwingþeye module
(Fig. 3G). Moreover, clonal analysis of a bs loss-of-function mutation
in the wing revealed that expression of the deiintron reporter, which
contains the deiwingþeye module, depends on Bs activity. Loss of
function of bs led to concomitant down-regulation of the deiintron
reporter and the endogenous dei gene (Fig. 3 H and I), supporting the
hypothesis that Bs regulates dei's expression in the wing via the
deiwingþeye module.
Muscle-speciﬁc CRMs reveal biphasic regulation of dei expression in
muscle cells
As described above, both the deiintron and deiupstream fragments
induced embryonic muscular expression, albeit with a temporal
difference. Whereas expression of the upstream reporter started at
early stage 12 and declined during stage 15, the expression of the
intronic reporter started later, at stage 14, and continued throughout
embryogenesis. We were able to identify two smaller regulatory
modules that retained the features of the bi-phasic muscular ex-
pression and named them accordingly deiearly-muscle and deilate-muscle
(Fig. 2). The 1204 bp deiearly-muscle regulatory region induced β-gal
protein expression in the visceral and somatic mesoderm from early
stage 12 onward, similarly to the deiupstream fragment (Fig. 4A–C and
G). In situ hybridization with a lacZ-speciﬁc probe demonstrated that
the expression of lacZ mRNA declined during stage 15, suggesting
that the prolonged β-Gal expression stems from β-Gal protein sta-
bility (Fig. 4A–C). In comparison, the 1366 bp deilate-muscle regulatory
Fig. 3. Two regulatory modules drive expression mainly in pupal tissues. (A–F) Anti-β-Gal staining of pupal tissues dissected 35–40 h APF from deiwingþeye–lacZ (A–D) and
deiwing-margin–lacZ (E–F) pupae. The deiwingþeye module induced expression in wing intervein cells (A), cone cells (B) and ES organs on the head, notum and appendages (C–D).
The deiwing-margin module induced expression in ES organs at the wing margin and appendages (E–F). (G) The consensus binding site of Bs, as suggested by in vitro DNA
binding speciﬁcities of its mouse ortholog (OnTheFly) and the two potential binding sites identiﬁed within the deiwingþeye module (overlapping sites in the þ and 
orientation). (H–I) Homozygous bs14 clones in pupal wings dissected 35–40 h APF. In mutant clones, absence of Bs expression (red, shown separately in H″ and I″) caused
signiﬁcant decrease in Dei expression (blue in H, shown separately in H‴) and deiwingþeye–lacZ expression (blue in I, shown separately in I‴).
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cles from stage 14 throughout stage 17, similarly to the deiintron-lacZ
reporter (Fig. 4D–F and I). Two chromatin-immunoprecipitation-
based screens identiﬁed D-Mef2 binding sites in both the intronic
and upstream regulatory regions of dei (Sandmann et al., 2006;
Zinzen et al., 2009). These binding sites are located within the two
identiﬁed CRMs, deilate-muscle and deiearly-muscle, indicating that both
modules could be under direct regulation of D-Mef2. To establish
whether D-Mef2 indeed regulates transcription from these two
CRMs in vivo, we examined the expression pattern of the two re-
porters in a mef2 null versus heterozygous background. Un-
expectedly, we found that the expression of the deilate-muscle reporter
was abolished inmef2 null embryos, whereas that of the deiearly-muscle
reporter was maintained (Fig. 4G–J). The requirement for Mef2, or
lack of, was also reﬂected by expression driven by the larger
deiintron-lacZ and deiupstream-lacZ reporters, respectively (data not
shown). Altogether, these results suggest that distinct CRMs induce
bi-phasic Dei expression in the embryonic musculature, initially
D-Mef2-independent, but at later stages under D-Mef2 regulation.
Two CRMs control dei expression in ChOs and tendon cells
The system controlling larval locomotion is comprised of
muscles and tendons that together form the contractile machinery
and ChOs that provide proprioception. Dei is expressed in all three
components of this system. In addition to the muscle-speciﬁc
regulatory modules described above, two additional CRMs were
identiﬁed that drive expression in tendon cells and/or ChOs.The 1128 bp deiattachment module, which is encompassed within
the deiupstream fragment (Fig. 2), induced expression from late stage
13 onward speciﬁcally in muscle- and ChO-attachment cells (CA
and LA cells) (Fig. 5A). Identifying a single regulatory module
capable of inducing expression in this repertoire of cell types is
consistent with previous works pointing to the high similarity
between these attachment cell types, such as the requirement for
the EGR protein Stripe (Sr) and the expression of downstream
effectors of Sr, such as Dei and Shortstop (Shot) (Inbal et al., 2004;
Klein et al., 2010).
The deiChO regulatory region was ﬁrst mapped to a 1353 bp
fragment lying upstream to dei's second exon (Fig. 2). This reg-
ulatory region induced embryonic expression in the ChO cap, li-
gament and CA cells (Fig. 5B); it also induced expression in ChO
cells during pupal development (Fig. 5C and data not shown).
Based on sequence conservation within deiChO (Fig. 5D), we further
delimited the functional CRM to a fragment harboring 389 bp,
which was sufﬁcient for driving ChO-speciﬁc expression (Fig. 5D
and E).
Both the deiattachment and the deiChO modules drove expression
in the CA cell, although in a different temporal pattern. In-situ
hybridization with a lacZ-speciﬁc probe revealed that expression
of the deiChO reporter in the CA cell started at early stage 12 and
was gradually lost during stage 15, while its expression in the cap
and ligament cells was maintained (Fig. 5F–H). In contrast, lacZ
expression driven by the deiattachment module started only in stage
14 and persisted throughout embryogenesis (Fig. 5I and J).
Fig. 4. Two regulatory modules drive temporally different pattern of expression in embryonic muscles and are affected differently by Mef2. (A–C) In situ hybridization with a
lacZ-speciﬁc probe to late stage 11 (A), 14 (B) and 16 (C) deiearly-muscle-lacZ embryos. lacZ mRNA is evident in the somatic mesoderm of Stage 11 and 14 embryos, but declines
during stage 15 and is hardly visible in muscles of stage 16 embryo. (D–F) In situ hybridization with a lacZ-speciﬁc probe to stage 13 (D), 15 (E) and 17 (F) deilate-muscle-lacZ
embryos. lacZ mRNA is not evident in the developing muscles until stage 14; it becomes evident in stage 15 and persists at later stages of embryogenesis. (G–H) Lateral view
of abdominal segments of embryos carrying the deiearly-muscle-lacZ reporter in a heterozygous (G) or homozygous (H) mef22.21 background, stained for βGal (red) and β3-
Tubulin (green). Note that in spite of the severe defects in muscle formation in mef22.21 mutant embryos, expression of the deiearly-muscle-lacZ reporter is maintained (arrows).
(I–J) Abdominal segments of embryos carrying the deilate-muscle-lacZ reporter in a heterozygous (I) or homozygous (J) mef22.21 background, stained for βGal (red) and β3-
Tubulin (green). Expression of the deilate-muscle-lacZ reporter is lost in homozygous mef22.21 embryo.
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plementary pattern of expression in the ChO cells. The deiChO drove
expression in the cap and ligament cells, whereas the deiattachment
module drove expression in the two attachment cells (CA and LA
cells; Fig. 5K and L).
The deiattachment, but not the deiChO module, is regulated by Sr
Sr is a major regulator of tendon and LA cell development
(Inbal et al., 2004); it is also required and sufﬁcient for the ex-
pression of dei in both of these cell types (Becker et al., 1997;
Frommer et al., 1996; Inbal et al., 2004; Vorbruggen et al., 1997). Sr
is also expressed in, and required for proper development of, ChO
ligament and CA cells, but it does not regulate dei's expression in
these cell types (Inbal et al., 2004; Klein et al., 2010).
To establish whether Sr regulates dei's transcription in the ChO
cells through the deiattachment and/or deiChO regulatory modules we
examined the effects of Sr on reporter gene expression driven by
these two modules. We ﬁrst examined the expression of the, lar-
ger, deiintron and deiupstream fragments in a sr loss-of-function
background and found that the expression of the deiupstream re-
porter was eliminated from the tendon and ChO attachment cells,
whereas the expression of the deiintron reporter remained largely
unchanged (Fig. 6A–D). In addition, we examined the expression
pattern induced by these regulatory modules in embryos that
ectopically expressed any of the two Sr splice variants, SrA or SrB(Frommer et al., 1996). We found that expression of either SrA or
SrB under the regulation of en-Gal4 was sufﬁcient to induce ec-
topic expression of the deiupstream reporter (Fig. 6I and J). In con-
trast, neither of these isoforms was able to induce ectopic ex-
pression of the deiintron reporter (data not shown). These results
demonstrate that Sr activates enhancer elements located within
the deiupstream, but not the deiintron, regulatory region.
Similarly to the two large fragments, expression induced by the
deiChO and deiattachment modules was also differentially affected by
the loss of sr. The deiChO reporter was unaffected by the loss of sr
and expression of the reporter was clearly evident in the ligament,
cap and CA cells of the ChO (Fig. 6E and F). In contrast, expression
of the deiattachment reporter was dramatically reduced. No β-Gal
expression was evident in tendons of the lateral transverse mus-
cles (n¼49); in 28.9% of the examined segments (n¼52) tendons
of row #1 did not show any β-Gal expression and low levels of
expression were evident in additional 28.8% of the segments. No
β-Gal expression was observed in the CA cells in 88.9% of the ex-
amined segment (n¼46) (Fig. 6G and H).
Altogether, these data suggest that dei's expression in the ChO
CA cells is regulated via a two-step process, in which the deiChO
module mediates initiation of dei expression, whereas the
deiattachment module maintains it. Accordingly, the two regulatory
modules are activated by different transcription factors in different
stages of CA cell development. In this context, Sr regulates dei’s
expression via the deiattachment module, which drives late
Fig. 5. Regulatory modules that drive expression in tendon cells and ChOs. (A) Lateral view of abdominal segments of an embryo carrying the deiattachment-lacZ reporter
stained with anti-Sr (green), anti-β-Gal (red) and anti αTub85E (blue) antibodies. Expression of the reporter is evident in the cap-attachment (CA) and ligament-attachment
(LA) cells of ChOs as well as in tendon cells. Expression of the reporter is shown separately in A′. (B) Abdominal segments of an embryo carrying the deiChO-lacZ reporter
stained with anti-Sr (green) and anti-β-Gal (red) antibodies. Expression of the reporter is evident in the CA, cap and ligament cells of the ChOs. Expression of the reporter is
shown separately in B′. (C) The anterior proximal region of a deiChO-lacZ pupal wing (30–35 h after pupariation) stained with anti-β-Gal. Both groups of ChOs associated with
the wing are evident. (D) A UCSC Genome Browser diagram of the dei locus with a higher-resolution view of the deiChO fragment. The bidirectional arrows at the bottom
represent the full-length (1353 bp) deiChO fragment and the shorter (389 bp) fragment that was found sufﬁcient for driving ChO-speciﬁc expression, as shown in E. (F–H)
In situ hybridization with a lacZ-speciﬁc probe to stage 13 (F), 15 (G) and 17 (H) deiChO-lacZ embryos. lacZ mRNA is evident in the CA cells (arrows) of stage 13 embryos, its
levels decline during stage 15 and it is no longer visible in stages 16–17 embryo. (I–J) In situ hybridization with a lacZ-speciﬁc probe to stage 14 (I) and 17 (J) deiattachment-lacZ
embryos. lacZ mRNA is evident in the CA cells of stage 14 embryos and persists at later stages of embryogenesis (arrows). (K–L) Cap and cap-attachment (CA) cells of a single
Lch5 organ of a deiChO-lacZ third instar larva (K) and a deiattachment-lacZ larva (L), stained with anti-αTub85E (green) and anti-β-Gal (red). The pattern of -β-Gal staining is
shown separately in K′ and L′.
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phase of expression. This observation is consistent with previous
ﬁndings showing that Sr plays a role in CA cell differentiation, but
is not required for earlier aspects of CA cell formation such as cell-
fate speciﬁcation (Inbal et al., 2004; Klein et al., 2010).
The deiattachment module is regulated directly by Sr
We next asked whether Sr regulates dei's expression directly
through the deiattachment module, or whether it feeds into this CRM
indirectly. Using the Genomatix program (http://www.genomatix.
de) we identiﬁed four potential binding sites of EGR, the mam-
malian counterpart of Sr, within the deiattachment module (Fig. 7A).
These sites conform to the suggested binding speciﬁcities of Sr as
deﬁned in bacterial one hybrid analysis and other prediction
methods (Shazman et al., 2014; Zhu et al., 2011). To establish
whether these binding sites are indeed functional, we usedsite-directed mutagenesis to substitute the conserved core of each
of them with irrelevant sequences. Four mutant versions of the
reporter construct were generated in the placZ-attB vector (Bischof
et al., 2007): deiattachment-m1 included a CCC4TTT transition in the
core of binding site 1, deiattachment-m2 included a GGG4AAA tran-
sition in the core of binding site 2, deiattachment-m3þ4 included a
CCC4TTT and a CGC4ATA alterations affecting the core of bind-
ing sites 3þ4, and dei-attachment-m1þ2þ3þ4 contained all of these
four alterations (Fig. 7A). The wildtype deiattachment-lacZ-attB con-
struct and the four mutant variants were integrated into the same
genomic insertion site and the induced pattern of β-Gal expression
was examined in the following cell types: anterior and posterior
CA cells, LA cell, tendons of the lateral transverse (LT) muscles and
tendons of the ventral longitudinal muscles (tendon row #1). The
inﬂuence of the introduced mutations on β-Gal expression was
examined for each cell type separately by comparing the percen-
tage of β-Gal expressing cells in each mutated strain to the control
Fig. 6. The deiattachment, but not the deiChO module, is regulated by Sr. (A–B) Embryos carrying the deiintron-lacZ reporter in a sr155 heterozygous (A) or homozygous
(B) background, stained with anti-β-Gal (green) and anti-Sr (red). Expression of the reporter is maintained in the CA cells (arrows) of sr155 mutant embryos. (C–D) Embryos
carrying the deiupstream-lacZ reporter in sr155 heterozygous (C) or homozygous (D) background, stained with anti-β-Gal (green), anti-Sr (red) and anti-αTub85E (blue).
Expression of the reporter is not maintained in the CA cells (arrows) of sr155 mutant embryos. (E–F) Embryos carrying the deiChO-GFP reporter in sr155 heterozygous (E) or
homozygous (F) background, stained with anti-Sr (red) and anti-αTub85E (blue). Expression of the reporter is maintained in the CA cells (arrows) of sr155 mutant embryos.
(G–H) Embryos carrying the deiattachment-lacZ reporter in sr155 heterozygous (G) or homozygous (H) background, stained with anti-β-Gal (green), anti-Sr (red) and anti-
αTub85E (blue). Expression of the reporter can be hardly seen in the CA cells (arrows) of sr155 mutant embryos. (I–J) deiupstream-lacZ embryos, which express either Sr-A (I) or
Sr-B (J) together with GFP under the regulation of en-gal4, stained with anti-β-Gal (blue). Both Sr-A and Sr-B can induce the deiupstream reporter expression when ectopically
expressed.
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were mutated, β-Gal expression was completely eliminated from
all of the examined cell types (Po0.0001) with the exception of LA
cells, 100% of which continued to express β-Gal from the mutated
reporter (Fig. 7B and C). Mutations affecting binding sites 1 or
2 alone did not alter β-Gal expression in any of the examined cell
types. Mutations affecting binding sites 3þ4 eliminated β-Gal
expression from more than 60% of tendon cells of the LT muscles
(Po0.004) and had a smaller effect on the expression in the
posterior CA cell. These results strongly support the idea that Sr is
a direct regulator of dei's transcription and that it functions
through binding to several binding sites within the deiattachment
fragment. The fact that deiattachment-lacZ expression persisted in the
LA cell even when all four sites were mutated, suggest that addi-
tional unidentiﬁed Sr site/s exist/s within the deiattachment frag-
ment. Alternatively, it is also possible that other, as yet uni-
dentiﬁed, transcription factors bind to sites within the deiattachmentfragment and positively regulate dei's expression in the LA cell
even in the absence of Sr binding.
A newly identiﬁed CRM regulates transcription of dei in the wing
in vivo
To further verify the relevance of the identiﬁed CRMs for the
regulation of dei in vivo, we performed rescue experiments using
three Gal4 drivers from the Janelia collection (Pfeiffer et al., 2008)
in which Gal4 expression is driven by different genomic fragments
that overlap with the identiﬁed CRMs (Fig. 2). Each of the tested
Gal4 strains was used to drive expression of a UAS-dei transgene in
a dei null background (dei33-2) and their ability to rescue dei loss-
of-function phenotype in the wing was determined. Since either
too little or too much of Dei expression can cause wing blistering
(Egoz-Matia et al., 2011), we chose to focus our rescue analysis on
the shape of the wing, mainly the typical pointed and kinked distal
Fig. 7. The deiattachmentmodule harbors functional Sr-binding sites. (A) Nucleotide sequence of the deiattachment fragment. The four potential Sr binding sites are shown in red.
Blue boxes mark the core sequences that were mutated in this study. The introduced mutations are indicated on the right. The consensus binding site of Sr is shown in the
red box (Fly Facor Survey). (B–C) Three abdominal segments of embryos carrying the deiattachment-WTlacZ reporter (B–B′) or the deiattachment-m1þ2þ3þ4lacZ reporter (C–C′)
stained with anti-Sr (green), anti-β-Gal (red) and anti αTub85E (blue) antibodies. Expression of the wildtype reporter is evident in the cap-attachment (CA, arrowheads) and
ligament-attachment (LA, arrows) cells of ChOs as well as in tendon cells. Expression of the mutant reporter is retained only in LA cells (arrows) and is lost from the CA cells
(arrowheads) and tendon cells.
Table 1
The effect of mutating Sr-binding sites on the expression pattern of the deiattachment-lacZ reporter in different cell types.
Percent of β-Gal-expressing cells
Mutated Sr binding sites in deiattachment Anterior CA cells Posterior CA cells Tendons of LT muscles Tendons of VL muscles LA cells
None 100 (n¼27) 74 (n¼27) 100 (n¼26) 100 (n¼27) 100 (n¼28)
Site #1 100 (n¼40) 97.5 (n¼40) 100 (n¼48) 100 (n¼51) 100 (n¼48)
Site #2 96.3 (n¼55) 52.7 (n¼55) 100 (n¼51) 100 (n¼55) 100 (n¼52)
Site #3þ4 94 (n¼67) 39.4 (n¼66) 36.8 (n¼68) 100 (n¼67) 100 (n¼61)
Site #1þ2þ3þ4 16.3 (n¼80) 0 (n¼77) 0 (n¼84) 11.8 (n¼68) 100 (n¼69)
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dei33-2 wings (n¼98). Expressing dei under the regulation of
GMR13A10-Gal4 in a dei mutant background resulted in a sig-
niﬁcant rescue of this phenotype and only 33.3% of the wings
presented such a phenotype (n¼114). The two other Gal4 drivers,GMR12D06-Gal4 and GMR12H09-Gal4, did not lead to a signiﬁcant
rescue (62.8%, n¼94 and 55.9%, n¼68, respectively) (Fig. 8A).
These results suggest that the deiwingþeye CRM, which is contained
within the GMR13A10-Gal4 regulatory fragment, induces the cor-
rect pattern of dei expression in the developing wing in vivo.
Fig. 8. Discrete enhancer elements mediate spatiotemporally restricted expression of dei. (A) The results of a rescue experiment in which the expression of dei was driven
under the regulation of different Gal4 drivers in a dei null background. The upper panel shows the four phenotypic categories used for phenotypic assessment. The graph
presents the percentage of wings exhibiting the mild or severe phenotypes in each tested genotype. (B) A schematic representation of the dei locus and the identiﬁed CRMs
(only CRMs that induce expression relevant to the endogenous gene are shown). The timing and pattern of expression driven by each CRM and identiﬁed upstream
regulators are indicated.
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Deconstructing the complexity of regulating common properties in
different cell types
Developmental programs are controlled by gene regulatory
networks, which are mediated by enhancers with spatially and
temporally restricted activities. Understanding the transcriptional
regulatory mechanisms employed to provide common properties
to different cell types holds a great challenge. One example is that
of adhesive molecules, such as integrin receptors, which are ex-
pressed in many different cell types in a tightly regulated fashion.
One way to gain insight into how proper levels of integrin ex-
pression are achieved in different cells types is by studying its
upstream transcriptional regulators. The bHLH transcription factor
Dei represents a good candidate for such a study due to its key role
in activating the expression of βPS integrin in various cell typeseach harboring a distinct constellation of transcription factors and
cell-signaling components.
Here we show that the ability of the dei gene to respond to a
variety of upstream regulators in different cell types, or within a single
cell in different stages of its development, is achieved by a modular
mechanism of regulation, whereby each regulatory module responds
to a different combination of transcription factors and activates Dei
expression in a speciﬁc spatio-temporal pattern. Using an in vivo re-
porter assay we identiﬁed six distinct CRMs located within two re-
gions of the dei locus that together recapitulated the full expression
pattern of the gene in embryos and pupae. Candidate upstream reg-
ulators were assigned to most of these modules based on their known
expression patterns and bioinformatics analysis for potential DNA
binding sites. Overall it seems that Dei is regulated, directly or in-
directly, by the central signaling pathways and transcription factors
typical to each cell type in which it is expressed: D-Mef2 in muscle
cells, Sr in tendon cells, Bs in the wing intervein cells and so on.
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summarized as follows (Fig. 8B). During embryonic stage 11, dei's
expression is induced in the mesoderm by the deiearly-muscle mod-
ule; this expression continues until stage 15 and is activated by
unknown signaling pathways. Concomitantly, during stage 11,
expression is induced via the deiChO module in the ChO CA, cap and
ligament cells. In the cap and ligament cells expression is con-
tinuous throughout embryogenesis, whereas in the CA cells, ex-
pression ceases during stage 15. It remains to be determined what
signaling pathways activate the deiChO-induced expression. During
stage 14, the deiattachment module, which is activated directly by Sr,
starts to drive gene expression in the ChO CA cells and in tendon
cells, and later on, in stage 16, also in ChO LA cells. Continuing into
late stage 14, expression induced via the deilate-muscle module is
activated in muscle cells by D-Mef2. In pupal stages, dei's ex-
pression is induced in the developing wing and eye through the
deiwingþeye module, possibly under the direct regulation of Bs in
the wing and possibly under the regulation of Cut in the cone cells
of the eye.
Insights into the function of the identiﬁed CRMs in the context of the
endogenous dei locus
The functionality and modular nature of the identiﬁed dei
regulatory modules could be inferred from the previously de-
scribed phenotype of the regulatory allele deie01478. This allele
harbors a PiggyBac-RB transposon inserted within the dei intron
upstream to the minimal deiChO fragment (Fig. 5D). We have pre-
viously reported that in homozygous deie01478 embryos Dei ex-
pression was lost from tendons and ChO attachment cells, whereas
it was markedly enhanced in ChO cap and ligament cells, as
compared to heterozygous siblings (Egoz-Matia et al., 2011). We
now know that this insertion leads to inhibition of gene expres-
sion from all regulatory modules located upstream to it. The only
module located downstream to the deie01478 insertion is deiChO,
which continues to induce expression of dei speciﬁcally in the cap
and ligament cells in this genetic background.
Inhibition of dei's transcription through the upstream CRMs is
probably not caused by the sheer size of the deie01478 transposon
(5.7 kb). Not only the CRMs were shown to be active irrespective of
their orientation or distance from the promoter, the deie01478 in-
sertion does not alter the distance between the CRMs and the
promoter, with the exception of the deiChO module, which remains
functional. The PiggyBac-RB transposon harbors a splice acceptor
site (Thibault et al., 2004) and thus could potentially cause pre-
mature splicing which may render transcription from the dei
promoter ineffective. In this scenario, activation of the deiChO
module is possible through an alternative promoter located be-
tween the insertion site and the coding exon. New alternative
promoters are continuously being identiﬁed and over 40% of ﬂy
genes use alternative promoters during ﬂy development (Batut
et al., 2013; Brown et al., 2014).
The cis-regulatory modules of dei, which integrate information
derived from the transcription factor landscape of each relevant
cell, are scattered along 9.4 kb of DNA located upstream to the
transcription start site and within the single intron of the gene. It
has been recently estimated that the ﬂy genome contains 50,000–
100,000 developmental enhancers and that most of these en-
hancers drive expression of their neighboring genes in a dynamic
tissue-speciﬁc pattern (Kvon et al., 2014). It was also estimated
that approximately one third of all enhancers are intragenic and
that the majority of ﬂy enhancers reside in the vicinity of their
target genes (Kvon et al., 2014). The dei tissue- and stage-speciﬁc
enhancers conform to the suggested principles. The locus contains
at least ﬁve enhancers that regulate expression of the dei tran-
script in a spatially and temporally restricted pattern. Three ofthese enhancers are intragenic.
Ghavi-Helm et al. have shown recently that most interactions
between enhancers to other enhancers and promoters with similar
expression pattern remain largely unchanged during development
and that transcription initiation from these enhancer–promoter
contacts is mediated by the release of paused polymerase (Ghavi-
Helm et al., 2014). In this respect too, the dei gene conforms to the
suggested mode of action. We have shown for example that there
is no switching between embryonic to adult ChO-speciﬁc en-
hancers; a single enhancer induces transcription of dei in ChOs in
both embryogenesis and in adult development. In addition, dei
was identiﬁed as a gene with stalled polymerase, a feature typical
of developmental control genes poised for fast activation later in
development (Zeitlinger et al., 2007).New insight into ChO development
In addition to the new insight gained into the regulation of dei's
expression, this work has shed light on a few unknown aspects of
ChO development. One of the important ﬁndings is the biphasic
nature of dei's regulation in ChO CA cells, which probably reﬂects a
change in cell differentiation status. The CA cell, unlike the LA cell,
is derived from the ChO lineage and is therefore inﬂuenced by the
Ato-induced program of ChO development. However, following
the primary determination of cell fates, when the ChOs start to
stretch and terminal differentiation ensues, the CA cell needs to
acquire the typical characteristics of a functional attachment cell,
similarly to the LA and tendon cells. As part of this shift in cellular
properties the deiChO module is switched off and the deiattachment
module is switched on to accommodate the required changes in
gene regulation. We do not know yet which transcription factors
regulate dei's expression through the deiChO module in the primary
phase of CA cell development, but we could show that Sr is the
major regulator of the deiattachment module in later stages of CA cell
differentiation. Disruption of the Sr binding sites within the
deiattachment module led to complete loss of reporter expression
from the tendon and CA cells, but interestingly, allowed for sig-
niﬁcant expression in LA cells. This observation points to yet un-
known differences in gene regulation networks and develop-
mental pathways between the two types of ChO attachment cells
(CA and LA).
Another important observation is that the deiChO module is
sufﬁcient to drive gene expression in the ligament and cap cells of
all ChOs in both embryos and adults (with the possible exception
of antennal ChO, unpublished data). This observation points to a
hitherto unrecognized similarity in the developmental programs
of different types of larval and adult ChOs and suggests that Dei
plays a role in the morphogenesis of all ChO's accessory cells. Very
little is known about the nature of ChO accessory cells in the adult.
Now, the newly identiﬁed dei regulatory modules provide a good
entry point to the identiﬁcation of upstream regulators and
downstream effectors pertinent to the speciﬁcation and function
of these cells.Acknowledgment
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